| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO And Chairman
1 company
Pham Quang X is a CEO And Chairman at Cadrenal Therapeutics, Inc.. Recent SEC Form 4 filings include 7 buys and 11 sells.
Estimated insider holdings value: $1.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 2025 | CVKD Cadrenal Therapeutics, Inc. | CEO And Chairman | Sell | 2,444 | $14.01 | $34,236.72 | -0.6% | -41.2% | - | |
| Oct 13, 2025 | CVKD Cadrenal Therapeutics, Inc. | CEO And Chairman | Sell | 3,600 | $14.09 | $50,706.00 | -0.9% | -39.0% | - | |
| Oct 2, 2025 | CVKD Cadrenal Therapeutics, Inc. | CEO And Chairman | Sell | 500 | $14.13 | $7,065.00 | -0.2% | -52.2% | - | |
| Oct 1, 2025 | CVKD Cadrenal Therapeutics, Inc. | CEO And Chairman | Sell | 1,300 | $14.01 | $18,213.00 | -0.3% | -52.9% | - | |
| Sep 25, 2025 | CVKD Cadrenal Therapeutics, Inc. | CEO And Chairman | Sell | 9,371 | $14.06 | $131,779.29 | -2.2% | -48.1% | - | |
| Aug 28, 2025 | CVKD Cadrenal Therapeutics, Inc. | CEO And Chairman | Sell | 5,029 | $13.99 | $70,355.71 | -1.2% | -29.4% | - | |
| Sep 5, 2023 | CVKD Cadrenal Therapeutics, Inc. | CEO And Chairman | Buy | 40,000 | $0.90 | $36,188.00 | +0.6% | -42.5% | -37.9% | |
| Sep 1, 2023 | CVKD Cadrenal Therapeutics, Inc. | CEO And Chairman | Buy | 70,000 | $0.91 | $63,945.00 | +0.4% | -48.4% | -43.0% |